Advertisement
Research ArticleDrug Discovery and Translational Medicine

The anti-inflammatory fungal compound (S)-Curvularin reduces pro-inflammatory gene expression in an in-vivo model of rheumatoid arthritis

Nadine Schmidt, Julia Art, Ingrid Forsch, Anke Werner, Gerhard Erkel, Mathias Jung, Sven Horke, Hartmut Kleinert and Andrea Pautz
Journal of Pharmacology and Experimental Therapeutics July 5, 2012, jpet.112.192047; DOI: https://doi.org/10.1124/jpet.112.192047
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleDrug Discovery and Translational Medicine

The anti-inflammatory fungal compound (S)-Curvularin reduces pro-inflammatory gene expression in an in-vivo model of rheumatoid arthritis

Nadine Schmidt, Julia Art, Ingrid Forsch, Anke Werner, Gerhard Erkel, Mathias Jung, Sven Horke, Hartmut Kleinert and Andrea Pautz
Journal of Pharmacology and Experimental Therapeutics July 5, 2012, jpet.112.192047; DOI: https://doi.org/10.1124/jpet.112.192047
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement